CONCLUSION
Minimally invasive techniques, which are successfully performed thanks to technological developments, are becoming more and more common. Robotic surgery systems have emerged as a potential facilitating factor for mitral valve surgery procedures. Nowadays, robotic mitral valve surgery has an important place in clinical practice in today’s technology. Proper patient selection is important in robotic heart surgery. In cases such as the presence of severe peripheral vascular disease, chest deformities such as pectus excavatus where adequate exposure cannot be provided, severe aortic insufficiency, ascending aortic aneurysm or atherosclerotic plaques in the ascending aorta, having advanced lungs attached to the thorax due to previous operations needs to be well evaluated.
When the results are evaluated as a whole, robotic mitral valve replacement surgery is an effective and reliable method due to the lower drainage and less need for blood transfusion compared to conventional methods, shorter ventilation time, intensive care and hospital stay. Despite the disadvantages of longer total perfusion and cross clamp times and technical equipment and trained personnel that require additional costs for operating theaters, it is an increasingly successful treatment method due to its early mobilization, faster recovery, better cosmetic result and increased quality of life compared to conventional methods. Our results, which are compatible with similar studies in the literature, show that the importance of robotic mitral valve surgery will continue to increase and become widespread. Thanks to the promising postoperative results of robotic surgery, we think that surgery will take its place in routine clinical applications in the future with technological developments.